Suppr超能文献

金色分枝杆菌和耻垢分枝杆菌对诺氟沙星的积累

Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis.

作者信息

Williams K J, Chung G A, Piddock L J

机构信息

Department of Infection, The Medical School, University of Birmingham, Edgbaston, United Kingdom.

出版信息

Antimicrob Agents Chemother. 1998 Apr;42(4):795-800. doi: 10.1128/AAC.42.4.795.

Abstract

The modified fluorescence method was used to determine the accumulation of norfloxacin by Mycobacterium aurum A+ and Mycobacterium smegmatis mc(2)155. By using an exogenous norfloxacin concentration of 10 microg/ml, a steady-state concentration (SSC) of 160 to 180 ng of norfloxacin/mg of cells was obtained for M. aurum, and an SSC of 120 to 140 ng of norfloxacin/mg of cells obtained for M. smegmatis. For both species of mycobacteria, the SSC was achieved within 5 min. The silicon oil method was investigated and gave higher SSCs than the modified fluorescence method. Further studies on the mechanism of norfloxacin accumulation by M. aurum were performed. An increase in the pH of the wash buffer from 7.0 to 9.0 did not significantly affect the final SSC obtained. Accumulation was nonsaturated over a norfloxacin concentration range of 0 to 100 microg/ml, and the proton motive force inhibitor 2,4-dinitrophenol (1 and 2 mM), whether it was added before or after norfloxacin was added, had no effect on the final SSC obtained. 2,4-Dinitrophenol also had no effect on norfloxacin accumulation by M. smegmatis. Furthermore, norfloxacin accumulation by M. aurum was unaffected by the presence of either Tween 80 or subinhibitory concentrations of ethambutol in the growth medium. Therefore, it is proposed that norfloxacin accumulation by mycobacteria occurs by simple, energy-independent diffusion.

摘要

采用改良荧光法测定了金色分枝杆菌A+和耻垢分枝杆菌mc(2)155对诺氟沙星的积累情况。在外源诺氟沙星浓度为10微克/毫升的情况下,金色分枝杆菌的诺氟沙星稳态浓度(SSC)为160至180纳克/毫克细胞,耻垢分枝杆菌的SSC为120至140纳克/毫克细胞。对于这两种分枝杆菌,5分钟内即可达到SSC。对硅油法进行了研究,其得到的SSC高于改良荧光法。对金色分枝杆菌积累诺氟沙星的机制进行了进一步研究。洗涤缓冲液的pH从7.0增加到9.0对最终获得的SSC没有显著影响。在0至100微克/毫升的诺氟沙星浓度范围内,积累是非饱和的,质子动力抑制剂2,4-二硝基苯酚(1和2毫摩尔),无论在添加诺氟沙星之前还是之后添加,对最终获得的SSC都没有影响。2,4-二硝基苯酚对耻垢分枝杆菌积累诺氟沙星也没有影响。此外,生长培养基中吐温80或亚抑制浓度的乙胺丁醇的存在对金色分枝杆菌积累诺氟沙星没有影响。因此,提出分枝杆菌积累诺氟沙星是通过简单且不依赖能量的扩散发生的。

相似文献

1
Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis.
Antimicrob Agents Chemother. 1998 Apr;42(4):795-800. doi: 10.1128/AAC.42.4.795.
2
Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.
J Antimicrob Chemother. 2000 Feb;45(2):159-65. doi: 10.1093/jac/45.2.159.
3
Intracellular accumulation of norfloxacin in Mycobacterium smegmatis.
Antimicrob Agents Chemother. 1995 Nov;39(11):2466-71. doi: 10.1128/AAC.39.11.2466.
4
Accumulation of KRM-1648 by Mycobacterium aurum and Mycobacterium tuberculosis.
J Antimicrob Chemother. 2000 May;45(5):681-4. doi: 10.1093/jac/45.5.681.
5
Evaluation of the intracellular accumulation of fluoroquinolones in mycobacteria by fluorometric assays.
Int J Mycobacteriol. 2020 Jan-Mar;9(1):34-38. doi: 10.4103/ijmy.ijmy_194_19.
6
Accumulation of norfloxacin by Bacteroides fragilis.
Antimicrob Agents Chemother. 2000 Sep;44(9):2361-6. doi: 10.1128/AAC.44.9.2361-2366.2000.
7
Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump.
J Bacteriol. 1996 Jul;178(13):3791-5. doi: 10.1128/jb.178.13.3791-3795.1996.
8
Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis.
Antimicrob Agents Chemother. 2004 Jul;48(7):2415-23. doi: 10.1128/AAC.48.7.2415-2423.2004.
9
Rapid drug susceptibility testing of mycobacteria in tissue culture medium.
Antimicrob Agents Chemother. 1983 Aug;24(2):268-72. doi: 10.1128/AAC.24.2.268.

引用本文的文献

1
Distribution of fluoroquinolones in the two aqueous compartments of .
Biochem Biophys Rep. 2020 Nov 13;24:100849. doi: 10.1016/j.bbrep.2020.100849. eCollection 2020 Dec.
2
Transformation of the antibacterial agent norfloxacin by environmental mycobacteria.
Appl Environ Microbiol. 2006 Sep;72(9):5790-3. doi: 10.1128/AEM.03032-05.

本文引用的文献

2
Proton-dependent multidrug efflux systems.
Microbiol Rev. 1996 Dec;60(4):575-608. doi: 10.1128/mr.60.4.575-608.1996.
4
Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
Antimicrob Agents Chemother. 1996 Aug;40(8):1768-74. doi: 10.1128/AAC.40.8.1768.
5
Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli.
Antimicrob Agents Chemother. 1996 Feb;40(2):491-3. doi: 10.1128/AAC.40.2.491.
6
gyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong Kong.
J Antimicrob Chemother. 1996 May;37(5):1032-4. doi: 10.1093/jac/37.5.1032.
7
Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump.
J Bacteriol. 1996 Jul;178(13):3791-5. doi: 10.1128/jb.178.13.3791-3795.1996.
8
High-throughput screen for detecting antimycobacterial agents.
Antimicrob Agents Chemother. 1995 Oct;39(10):2235-8. doi: 10.1128/AAC.39.10.2235.
9
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
Antimicrob Agents Chemother. 1995 Dec;39(12):2620-4. doi: 10.1128/AAC.39.12.2620.
10
Intracellular accumulation of norfloxacin in Mycobacterium smegmatis.
Antimicrob Agents Chemother. 1995 Nov;39(11):2466-71. doi: 10.1128/AAC.39.11.2466.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验